Literature DB >> 1560016

Exon skipping in purine nucleoside phosphorylase mRNA processing leading to severe immunodeficiency.

L G Andrews1, M L Markert.   

Abstract

We report a defect in splicing of precursor messenger RNA (pre-mRNA) resulting from a naturally occurring mutation of the gene encoding purine nucleoside phosphorylase (PNP) in a patient with PNP-deficient severe combined immunodeficiency. This defects results from a G to T transversion at the terminal nucleotide of exon 2 within the 5' splice site of intron 2 and causes skipping of exon 2 during processing of PNP pre-mRNA. Translation of the misspliced mRNA results in a reading frameshift at the exon 1-exon 3 junction. The predicted polypeptide encoded by the aberrant mRNA is severely truncated, terminating at 31 amino acids. Only 4 residues at the NH2 terminus of the polypeptide correspond to PNP amino acids. Otherwise the translation product of the misspliced mRNA differs completely from PNP in amino acid sequence and has no PNP activity. The finding of exon skipping in PNP is the first report of a splicing defect resulting in PNP-deficient severe combined immunodeficiency. Analysis of the genomic context of the G-1 to T mutation of the 5' splice site lends support for the exon definition model of pre-mRNA splicing and contributes to the understanding of splice site selection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1560016

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Clinical characteristics and mutation analysis of X-linked severe combined immunodeficiency in China.

Authors:  Cui Zhang; Zhi-Yong Zhang; Jun-Feng Wu; Xue-Mei Tang; Xi-Qiang Yang; Li-Ping Jiang; Xiao-Dong Zhao
Journal:  World J Pediatr       Date:  2011-11-21       Impact factor: 2.764

2.  Molecular mechanisms leading to null-protein product from retinoschisin (RS1) signal-sequence mutants in X-linked retinoschisis (XLRS) disease.

Authors:  Camasamudram Vijayasarathy; Ruifang Sui; Yong Zeng; Guoxing Yang; Fei Xu; Rafael C Caruso; Richard A Lewis; Lucia Ziccardi; Paul A Sieving
Journal:  Hum Mutat       Date:  2010-11       Impact factor: 4.878

3.  Abnormal muscle development in the heldup3 mutant of Drosophila melanogaster is caused by a splicing defect affecting selected troponin I isoforms.

Authors:  J A Barbas; J Galceran; L Torroja; A Prado; A Ferrús
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

4.  Diverse growth hormone receptor gene mutations in Laron syndrome.

Authors:  M A Berg; J Argente; S Chernausek; R Gracia; J Guevara-Aguirre; M Hopp; L Pérez-Jurado; A Rosenbloom; S P Toledo; U Francke
Journal:  Am J Hum Genet       Date:  1993-05       Impact factor: 11.025

5.  A novel point mutation (G-1 to T) in a 5' splice donor site of intron 13 of the dystrophin gene results in exon skipping and is responsible for Becker muscular dystrophy.

Authors:  Y Hagiwara; H Nishio; Y Kitoh; Y Takeshima; N Narita; H Wada; M Yokoyama; H Nakamura; M Matsuo
Journal:  Am J Hum Genet       Date:  1994-01       Impact factor: 11.025

6.  Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype.

Authors:  I Santisteban; F X Arredondo-Vega; S Kelly; A Mary; A Fischer; D S Hummell; A Lawton; R U Sorensen; E R Stiehm; L Uribe
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

7.  A 5' splice site mutation affecting the pre-mRNA splicing of two upstream exons in the collagen COL1A1 gene. Exon 8 skipping and altered definition of exon 7 generates truncated pro alpha 1(I) chains with a non-collagenous insertion destabilizing the triple helix.

Authors:  J F Bateman; D Chan; I Moeller; M Hannagan; W G Cole
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

8.  Mutations of the microsomal triglyceride-transfer-protein gene in abetalipoproteinemia.

Authors:  T M Narcisi; C C Shoulders; S A Chester; J Read; D J Brett; G B Harrison; T T Grantham; M F Fox; S Povey; T W de Bruin
Journal:  Am J Hum Genet       Date:  1995-12       Impact factor: 11.025

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.